Home
    Investor > Company > Corporate governance > Articles of association

    ARTICLES OF ASSOCIATION FOR THRANE & THRANE A/S

    (10-11-2011)

    Download PDF

     (Company reg. no. 6572 4618)

     

    1.         NAME

    1.1        The name of the Company is Thrane & Thrane A/S.

     

    2.         OBJECTS

    2.1        The objects for which the Company is established are to carry on engineering, commercial and manufacturing business.

     

    3.         SHARE CAPITAL, SHARES AND CANCELLATION

    3.1        The share capital of the Company is DKK 113,352,880 divided into shares of DKK 20 or multiples thereof. The share capital has been fully paid up.

    3.2        All shares shall be issued to bearer, but may be recorded in the name of the holder in the Company's register of shareholders. The register of shareholders shall be kept by VP Investor Services A/S, Weidekampsgade 14, 2300 Copenhagen S, Denmark, which has been chosen as registrar for the Company.

    3.3        The shares shall be negotiable instruments and the transferability of the shares shall not be subject to any limitations.

     

    3.4        No share shall confer special rights upon the holder and no shareholder shall be bound to have his shares redeemed, whether wholly or partly, by the Company or others.

     

    3.5        The shares shall be issued through a central securities depository. Payment of dividends, etc. shall be made in accordance with the rules thereon stipulated by the central securities depository.

     

    3.6        Shares alleged to have been lost may be cancelled extra-judicially in accordance with the Danish rules of law in force from time to time.

     

     

    3.A.     Authorization to increase the share capital

    3.A.1    The Board of Directors shall be authorized to increase the Company's share capital by up to nominally DKK 562,000 through one or more issues or through issuing of bonus shares to the employees of the Company or its subsidiaries. In case of such capital increase, the Board of Directors shall decide on the time for and the terms and conditions of the capital increase and shall be entitled to decide that the pre-emption rights of the existing shareholders shall not apply, wholly or partly. The Board of Directors shall be entitled to decide that the issue price shall be below market price. The authorization shall be valid until the date of the annual general meeting in 2012.

     

    3.A.2    The Board of Directors shall be authorized to increase the Company's share capital by up to nominally DKK 100,000,000 through one or more issues. In the event of an increase of the share capital at market price, including as payment for the Company's acquisition of an existing business, the Board of Directors shall be entitled to decide that the pre-emption rights of existing shareholders shall not apply, wholly or partly. In case of such capital increase the Board of Directors shall decide on the time for and the terms and conditions of the capital increase. The authorization shall be valid until the date of the annual general meeting in 2012.

     

    3.A.3    The Board of Directors shall be authorized to increase the Company's share capital through one or more issues of warrants to the management and the employees of the Company or its subsidiaries without granting pre-emption rights to the existing shareholders. The maximum share capital to be subscribed on the basis of such warrants shall be nominally DKK 2,660,000. The Board of Directors shall decide on the time for and the terms and conditions of the capital increase. The Board of Directors may decide that the issue price shall be below market price. The authorization shall be valid until the date of the annual general meeting in 2012.

     

    3.A.4    New shares issued under the authorizations in 3.A.1-3.A.3 shall be issued to bearer and they shall be negotiable instruments and freely transferable. No shareholder shall be bound to have his shares redeemed, whether wholly or partly, by the Company or others, and none of the new shares shall carry any special rights. The shares shall be issued through a central securities depository. 

     

    3.A.5    The Board of Directors shall be authorized to make such amendments to the Articles of Association of the Company as may be required as a consequence of the Board of Directors exercising the authorizations of this 3.A.

     

    3.B–3.G (Omitted)


    3.H.     Warrants

    3.H.1    Pursuant to Section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on December 19, 2001 the Board of Directors has issued warrants for subscription of 45,000 shares of a nominal value of DKK 20 each. At the same time the required capital increase has been resolved upon.

     

    The warrants have been issued without granting pre-emption rights to the existing shareholders and shall be subscribed for on separate subscription lists. The deadline for subscription for the warrants shall be November 30, 2003.

     

    Each warrant vested during the period from November 23, 2004 until the release of the profit announcement for the year ending April 30, 2005 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at the price of DKK 254.29.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2005 until the release of the profit announcement for the year ending April 30, 2006 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2005, plus 10%.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2006 until the release of the profit announcement for the year ending April 30, 2007 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2006, plus 10%.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2007 until the release of the profit announcement for the year ending April 30, 2009 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2007, plus 10%.

     

    However, the subscription price shall not be lower than the market price at the time of allocation.

     

    Any shares subscribed for by exercising the warrants shall belong to the same class of shares as the existing shares and shall otherwise in all respects carry the same rights as the existing shares.

     

    3.H.2    The warrants allocated shall vest, provided that the warrant holder is a member of the Company's Board of Directors or is in continuing employment with the Company or any of its subsidiaries. Warrants shall vest by 1/36 of warrants allocated each month after the time of allocation.

     

    The warrant holder shall exercise the vested warrants in multiples of 250 within a period of four years from the date they vest (hereinafter the "Term"). However, the warrant holder shall always be entitled to exercise vested, but not exercised warrants in the last Exercise Period as defined below prior to the expiry of the Term whether or not the number of vested, but not exercised warrants is less than 250.

     

    Within the Term vested warrants shall only be exercisable within one of the following two periods ("Exercise Period"):

     

    (i)       For a period of six weeks from the Company's profit announcement to NASDAQ OMX Copenhagen A/S.

     

    (ii)      For a period of six weeks from the Company's six-month interim profit announcement to NASDAQ OMX Copenhagen A/S.

     

    Exercise shall only be possible where it is not in contravention of the rules of law and the internal rules on trading in the Company's shares, including insider trading and speculative transactions, in force from time to time.

     

    The warrant holder shall exercise vested warrants by notifying the Company's Board of Directors represented by its Management Board in writing within the Exercise Period indicating the number of warrants he wishes to exercise and paying to the Company the total amount due for subscription for the shares.

     

    On receipt of the written notification of exercise, the Company shall be under an obligation to arrange for completion of the required share capital increase within 30 days of receipt by the Company of the notification.

     

    3.H.3    Irrespective of 3.H.2 the warrant holder shall be entitled to exercise his vested warrants where:

     

    (i)       a situation arises that triggers a mandatory bid pursuant to Section 31 of the Danish Securities Trading Act, or

     

    (ii)      the Company's shares are delisted from NASDAQ OMX Copenhagen A/S.

     

    The extraordinary right to exercise vested warrants pursuant to the above provision is conditional upon the Board of Directors represented by the Company's Management Board having been notified in writing by the warrant holder indicating the number of warrants that he wishes to exercise and paying to the Company the total amount due for subscription for the shares on the basis of the warrants within 3 weeks after expiry of the time stipulated for acceptance (or the prolonged time for acceptance) in the bid, or within three weeks after the decision to delist has been announced through NASDAQ OMX Copenhagen A/S.

     

    3.H.4    Where the warrant holder wishes to exercise his vested warrants following:

     

    (i)       an increase in the Company's share capital at a price which is more than 5 per cent below the market price (except for capital increases which are completed pursuant to the authorizations granted to the Board of Directors in 3.A.1 and 3.A.3, respectively),

     

    (ii)      the issue by the Company of convertible bonds, convertible loans or similar instruments or warrants (except for those covered by these paragraphs) entitling the holder to acquire shares in the Company at a price which is more than 5 per cent below the market price,

     

    (iii)      the issue of bonus shares (except for bonus shares issued pursuant to the authorization granted to the Board of Directors in 3.A.1), or

     

    (iv)     a reduction in the Company's share capital in which connection the Company distributes funds to the existing shareholders at a price which is more than 5 per cent higher than the market price

     

    the exercise price shall be adjusted to reasonably compensate the warrant holder for the reduction in the value of the warrants which may have been caused by the specific event. The compensation shall be finally determined by one of the Company's auditors to be appointed by the Board of Directors.

     

    Where vested warrants are exercised following:

     

    (i)       a merger or a demerger of the Company, or

     

    (ii)      similar changes in the Company's capital structure,

     

    the warrant holder shall receive shares in the Company, if required at another price, or in other companies or in some other way receive compensation. The adjustment or compensation shall be finally determined by one of the Company's auditors to be appointed by the Board of Directors.

     

    Where the warrant holder wishes to exercise his vested warrants following:

     

    (i)       an increase at a premium of the Company's share capital, or

     

    (ii)      a reduction in the Company's share capital in which connection the Company distributes funds to the existing shareholders for an amount lower than the amount with which the capital has been reduced

     

    the exercise price shall be adjusted in order that the market value of the warrants shall not be altered as a result of the specific event. The amount of adjustment shall be finally determined by one of the Company's auditors to be appointed by the Board of Directors.

     

    3.i.      Warrants

    3.I.1      Pursuant to Section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on December 19, 2001 the Board of Directors has issued warrants for subscription of 51,300 shares of a nominal value of DKK 20 each. At the same time the required capital increase has been resolved upon.

     

    The warrants have been issued without granting pre-emption rights to the existing shareholders and shall be subscribed for on separate subscription lists. The deadline for subscription for the warrants shall be November 30, 2003.

     

    Each warrant vested during the period from November 20, 2003 until the release of the profit announcement for the year ending April 30, 2004 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price DKK 174.81.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2004 until the release of the profit announcement for the year ending April 30, 2005 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2004, plus 10%.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2005 until the release of the profit announcement for the year ending April 30, 2006 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2005, plus 10%.

     

    Each warrant vested during the period from the release of the profit announcement for the year ending April 30, 2006 until the release of the profit announcement for the year ending April 30, 2007 shall entitle the warrant holder to subscribe one share of DKK 20 nominal value in the Company at a price equivalent to the share price per share of DKK 20 nominal value as quoted by NASDAQ OMX Copenhagen A/S five days after the release of the profit announcement for the year ending April 30, 2006, plus 10%.

     

    However, the subscription price shall not be lower than the market price at the time of allocation.

     

    Any shares subscribed for by exercising the warrants shall belong to the same class of shares as the existing shares and shall otherwise in all respects carry the same rights as the existing shares.

     

    3.I.2      The warrants shall otherwise be subject to the terms and conditions in 3.H.2 – 3.H.4 above.

     

    3.J.     Warrants

    3.J.1     Pursuant to Section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on June 27, 2006 the Board of Directors has on November 22, 2006 issued warrants for subscription of 62,250 shares of a nominal value of DKK 20 each. At the same time the required capital increase has been resolved upon.

     

    The terms and conditions of the warrants are set out in Appendix 1 hereto.

     

    3.K.    Warrants

    3.K.1    Pursuant to section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on June 27, 2007, the Board of Directors has on July 4, 2007 issued warrants for subscription of 132,000 shares with a nominal value of DKK 20 each. At the same time, the required capital increase has been resolved upon.

     

    3.K.2    The terms and conditions of the warrants are set out in Appendix 2 hereto.

     

    3.L.     Warrants

    3.L.1     Pursuant to section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on June 27, 2007, the Board of Directors has on August 23, 2007 issued warrants for subscription of 50,000 shares with a nominal value of DKK 20 each. At the same time, the required capital increase has been resolved upon.

     

    3.L.2     The terms and conditions of the warrants are set out in Appendix 3 hereto.

     

    3.M.     WARRANTS

     

    3.M.1    Pursuant to section 40 b of the Danish Public Companies Act and an authorization granted by the general meeting on June 27, 2007, the Board of Directors has on November 21, 2007 issued warrants for subscription of 85,000 shares with a nominal value of DKK 20 each. At the same time the required capital increase has been resolved upon.

     

    3.M.2    The terms and conditions of the warrants are set out in Appendix 4 hereto.

     

    4.         GENERAL MEETINGS, ETC.

    4.1        General meetings shall be held in the Capital Region.

     

    4.2        The annual general meeting shall be held each year within four months after the end of the financial year.

    4.3        Extraordinary general meetings shall be held whenever the Board of Directors or the auditor so request. An extraordinary general meeting shall furthermore be held when shareholders who in aggregate hold at least one twentieth of the share capital so request. In such case, the general meeting shall be convened within 14 days after receipt of the request.

     

    4.4        General meetings shall be convened by the Board of Directors not earlier than five weeks and not later than three weeks before the general meeting. The notice convening the meeting will be posted on the Company's website, www.thrane.com, and published via the Danish Commerce and Companies Agency's electronic information system. At the same time, the notice will be sent to all shareholders recorded in the Company's register of shareholders, who have so requested. The notice shall contain the agenda for the general meeting and such other information as the Danish Companies Act prescribes.

     

    4.5        A shareholder's right to attend a general meeting and to vote is determined relative to the shares held by the shareholder at the record date. The record date is one week before the general meeting. The shares held by each shareholder at the record date are calculated on the basis of registration of the shareholders' ownership in the register of shareholders, on the basis of notifications about ownership received by the Company for entry into the register of shareholders, but which have not yet been recorded in the register of shareholders, or by presentation of documentation from the shareholder's account controller from the record date.

     

    4.6        Shareholders, who are entitled to attend a general meeting, see 4.5 above, may attend the general meeting provided they have requested an admission card not later than three days before the date of the general meeting.

     

    4.7        Shareholders may attend in person or be represented by proxy, and the shareholder and his proxy may attend together with an adviser.

     

    Voting rights may be exercised according to an instrument of proxy issued to a person who need not be a shareholder in the Company. Proxies may be revoked at any time. Such revocation shall be in writing and take place by contacting the Company. However, proxy to the Company's management may not be given for a period exceeding one year and must be  given in respect of a specific general meeting with an agenda known in advance.

     

    4.8        For a period of three weeks before the general meeting up to and including the date of the general meeting, a copy of the notice convening the meeting with the agenda, the complete proposals, documents to be submitted at the general meeting, information about voting rights and capital at the time of the notice and forms for nominating proxies and voting by correspondence will be posted on the Company's website, www.thrane.com. At the same time, the annual report shall be forwarded to all registered shareholders having submitted a written request to this effect.

     

    4.9        A shareholder is entitled to have a specific issue included in the agenda of the annual general meeting provided the shareholder has submitted a written request to that effect to the Board of Directors not later than six weeks before the date of the general meeting. If the proposal has been received by the Company after such deadline, the Board of Directors determines whether the proposal has, nevertheless, been submitted in due time before the general meeting to be included in the agenda.

     

    4.10      Shareholders entitled to attend a general meeting, see 4.5 of the Articles of Association, may also vote by correspondence. Votes by correspondence must be submitted in writing and must be received by the Company not later than two days before the general meeting.

     

    4.11      All communication from the Company to the individual shareholders to be exchanged between the Company and the shareholders pursuant to the Articles of Association, the Danish Companies Act or stock exchange legislation, including notices to convene general meetings and forwarding of annual reports, may take place electronically by e-mail. However, the Company may at any time elect to use ordinary mail as an alternative or supplement to e-mail. General notices are posted on the Company's website and are made available by such other means as are prescribed by law.

     

    Shareholders may communicate with the Company by e-mail or by ordinary mail.

     

    The Company shall request registered shareholders to submit an e-mail address to which communications etc. may be sent. Shareholders are responsible for ensuring that the Company has the correct e-mail address at all times.

     

    Further information about the requirements of systems used and the procedure for electronic communication is available on the Company's website, www.thrane.com.

     

    5.         AGENDA

    5.1        At the annual general meeting, the annual report shall be presented, and the agenda shall include:

    1. The Board of Directors' report on the activities of the Company during the past financial year.
    2. Presentation of the annual report for adoption and a resolution ratifying the acts of the Board of Directors and the Management Board.
    3. Submission of proposal for application of profits or covering of losses appearing from the annual report adopted.
    4. Election of members to the Board of Directors.
    5. Appointment of Auditors.
    6. Any proposals from the Board of Directors or the shareholder

    6.         CHAIRMAN OF GENERAL MEETINGS

    6.1        A Chairman appointed by the Board of Directors shall preside over the general meeting and ensure that the general meeting is conducted in a responsible and appropriate manner. The Chairman of the meeting is vested with the necessary powers for this purpose.

     

    7.         VOTING

    7.1        Each shareholding of DKK 20 shall have one vote at the Company's general meeting.

     

    7.2        At the general meeting, resolutions can only be passed on proposals specified on the agenda.

     

    7.3        All resolutions by the general meeting shall be passed by a simple majority of votes unless the Danish Companies Act contains special provisions on representation and majority.

     

    7.4        The proceedings at the general meeting shall be recorded in the Company's minute book, which shall be signed by the Chairman of the general meeting and by the members of the Board of Directors present at the general meeting.

     

    8.         MANAGEMENT

    8.1        The general meeting shall elect not less than three and not more than seven members to the Board of Directors. The members thus elected shall resign at each year's annual general meeting, but shall be eligible for re-election.

     

    8.2        The Board of Directors shall, from among their own number, elect a Chairman and may elect a Deputy Chairman who, in the Chairman's absence and in every respect, shall have the same powers as the Chairman.

     

    8.3        Board resolutions shall be passed by a simple majority of votes.

     

    8.4        The Board of Directors shall lay down its own rules of procedure for the perform­ance of its duties.

     

    8.5        The proceedings at board meetings shall be recorded in the Company's minute book which shall be signed by all the members of the Board of Directors.

     

    8.6        The members of the Board of Directors shall be remunerated annually as fixed in the annual report for the financial year in question.

     

    8.7        The Board of Directors shall appoint the Management Board and may authorize one person alone or a number of persons jointly to sign for the Company by procuration.

     

    8.8        The Company has defined guidelines for incentive pay to members of the Company's Board of Directors and Management Board. The guidelines as approved by the shareholders in general meeting are posted on the Company's website, www.thrane.com.

     

    9.         POWER TO BIND THE COMPANY

    9.1        The Company shall be bound by the joint signatures of one member of the Management Board and the Chairman of the Board of Directors or two ordinary members of the Board of Directors or by the joint signatures of three members of the Board of Directors.

     

    10.       AUDIT

    10.1      The accounts of the Company shall be audited by one state-authorized public accountant.

     

    10.2      The Auditors shall be appointed by the annual general meeting for the period until the close of the next annual general meeting.

     

    11.       FINANCIAL YEAR

     

    11.1      The financial year of the Company shall be 1 May to 30 April.

     

    As amended on November 10, 2011.

     



    © 2008 Thrane & Thrane A/S. All rights reserved. - Legal Notices Privacy and Trademark